[go: up one dir, main page]

NO964966L - Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav - Google Patents

Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav

Info

Publication number
NO964966L
NO964966L NO964966A NO964966A NO964966L NO 964966 L NO964966 L NO 964966L NO 964966 A NO964966 A NO 964966A NO 964966 A NO964966 A NO 964966A NO 964966 L NO964966 L NO 964966L
Authority
NO
Norway
Prior art keywords
mixtures
lactobacillus strains
human origin
lactobacillus
strains
Prior art date
Application number
NO964966A
Other languages
English (en)
Other versions
NO964966D0 (no
NO316644B1 (no
Inventor
Lorenzo Morelli
Vittorio Bottazzi
Luigia Gozzini
Christoph De Haen
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26331139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO964966(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ITMI941073A external-priority patent/IT1269838B/it
Priority claimed from ITMI941773A external-priority patent/IT1274733B/it
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of NO964966D0 publication Critical patent/NO964966D0/no
Publication of NO964966L publication Critical patent/NO964966L/no
Publication of NO316644B1 publication Critical patent/NO316644B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO19964966A 1994-05-26 1996-11-22 Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav NO316644B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI941073A IT1269838B (it) 1994-05-26 1994-05-26 Ceppi di lattobacilli di origine umana e loro usi
ITMI941773A IT1274733B (it) 1994-08-25 1994-08-25 Ceppo del genere lactobacillus di origine umana e suoi usi
PCT/EP1995/001886 WO1995033046A1 (en) 1994-05-26 1995-05-18 Lactobacillus strains of human origin, their compositions and uses thereof

Publications (3)

Publication Number Publication Date
NO964966D0 NO964966D0 (no) 1996-11-22
NO964966L true NO964966L (no) 1997-01-23
NO316644B1 NO316644B1 (no) 2004-03-22

Family

ID=26331139

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964966A NO316644B1 (no) 1994-05-26 1996-11-22 Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav

Country Status (18)

Country Link
US (1) US5709857A (no)
EP (1) EP0760848B1 (no)
JP (1) JP3653277B2 (no)
CN (1) CN1094972C (no)
AT (1) ATE163042T1 (no)
AU (1) AU686389B2 (no)
BR (1) BR9507752A (no)
CA (1) CA2191213C (no)
DE (2) DE760848T1 (no)
DK (1) DK0760848T3 (no)
ES (1) ES2099056T3 (no)
FI (1) FI119059B (no)
GR (2) GR970300016T1 (no)
HU (1) HU220190B (no)
MX (1) MX9605807A (no)
NO (1) NO316644B1 (no)
NZ (1) NZ287420A (no)
WO (1) WO1995033046A1 (no)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN175495A0 (en) * 1995-03-14 1995-04-13 University Of New England, The Method and composition for the prevention of the over production of acid
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
IT1289159B1 (it) * 1997-01-08 1998-09-29 Yurta S R L Composizioni farmaceutiche e alimentari a base di batteri del genere acetobacter
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
US7202219B1 (en) * 1998-02-24 2007-04-10 Md Foods Amba Use of D-tagatose as a prebiotic food component
DE69802260T2 (de) 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US6080401A (en) * 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
HK1046864B (zh) * 1999-03-11 2006-10-27 雀巢制品公司 能够预防病原细菌和轮状病毒引起的腹泻的乳杆菌菌株
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
US20040105848A1 (en) * 1999-04-30 2004-06-03 Natarajan Ranganathan Enteric dialysis compositions and methods
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US6641808B1 (en) * 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
AU2001233529A1 (en) * 2000-02-10 2001-08-20 Andrew W. Bruce Probiotic therapy for newborns
US6719991B2 (en) * 2000-06-09 2004-04-13 Baylor College Of Medicine Combination of antimicrobial agents and bacterial interference to coat medical devices
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
JP5186077B2 (ja) 2000-12-18 2013-04-17 プロバイオヘルス・エルエルシー ラクトバシラス−カゼイｋｅ０１株から得られたプロバイオティック化合物
US7060687B2 (en) * 2001-02-07 2006-06-13 Genmont Biotechnology Co. Live vaccines for allergy treatment
NO318426B1 (no) * 2001-10-02 2005-04-18 Neurozym Biotech As Et materiale for a senke konsentrasjonen av patogene tarmpeptider
US8147821B2 (en) 2002-02-21 2012-04-03 Grain Processing Corporation Method for drying biomaterials
PT1485463E (pt) 2002-03-21 2008-12-30 Bifodan As Estirpes de lactobacillus
US20080126195A1 (en) * 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
CA2547144C (en) 2005-05-16 2010-02-02 Grain Processing Corporation Method for drying spent filter media
CN101273736B (zh) * 2007-03-28 2012-08-08 北京弗蒙特生物技术有限公司 一种在常温下保持高活菌数的发酵乳的制备方法
ATE447329T1 (de) * 2007-07-13 2009-11-15 Unilever Nv Nahrungsmittel mit bakterien und sorbitan- fettsäure
US20090041727A1 (en) * 2007-08-08 2009-02-12 Conjugon, Inc. Compositions and Methods for Microbe Storage and Delivery
US20110223248A1 (en) * 2007-12-12 2011-09-15 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
KR101003149B1 (ko) * 2008-10-31 2010-12-22 전남대학교산학협력단 병변 치료용 박테리아 기반의 마이크로로봇
EP2206506A1 (en) 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2248908A1 (en) 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
WO2011009848A2 (en) 2009-07-20 2011-01-27 Bracco Spa Therapeutic use of probiotics
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
NZ618935A (en) 2010-08-04 2014-03-28 Karma Medical Prod Co Ltd Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
SG193348A1 (en) 2011-03-09 2013-10-30 Univ Minnesota Compositions and methods for transplantation of colon microbiota
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
BR112015006568B1 (pt) 2012-09-25 2022-07-05 Aquilon Cyl S.L. Uso de uma composição e composição
BR112017024264B1 (pt) 2015-05-14 2022-07-12 Crestovo Holdings Llc Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
EP3998072A1 (en) 2015-05-22 2022-05-18 Arizona Board of Regents on behalf of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
CA3064773A1 (en) 2017-05-26 2018-11-29 Crestovo Holdings Llc Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CN113164527A (zh) 2018-09-27 2021-07-23 芬奇治疗控股有限责任公司 用于治疗癫痫和相关障碍的组合物和方法
CA3147629A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4946791A (en) * 1986-10-02 1990-08-07 Bio Techniques Laboratories, Inc. Novel strain of Lactobacillus acidophilus
US5179020A (en) * 1991-08-19 1993-01-12 Bio Techniques Laboratories, Inc. Antibiotic resistant strain of lactobacillus acidophilus
EP0577904B1 (fr) * 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique

Also Published As

Publication number Publication date
EP0760848A1 (en) 1997-03-12
AU686389B2 (en) 1998-02-05
AU2613995A (en) 1995-12-21
ES2099056T1 (es) 1997-05-16
HU9603251D0 (en) 1997-01-28
MX9605807A (es) 1997-12-31
EP0760848B1 (en) 1998-02-04
CA2191213A1 (en) 1995-12-07
GR970300016T1 (en) 1997-05-31
HU220190B (hu) 2001-11-28
CN1094972C (zh) 2002-11-27
DK0760848T3 (da) 1998-09-23
FI964681A0 (fi) 1996-11-25
JP3653277B2 (ja) 2005-05-25
CN1154715A (zh) 1997-07-16
ES2099056T3 (es) 1998-04-01
GR3026758T3 (en) 1998-07-31
ATE163042T1 (de) 1998-02-15
DE69501591D1 (de) 1998-03-12
WO1995033046A1 (en) 1995-12-07
DE760848T1 (de) 1997-08-28
DE69501591T2 (de) 1998-06-10
US5709857A (en) 1998-01-20
NZ287420A (en) 1997-12-19
JPH10500577A (ja) 1998-01-20
HUT75555A (en) 1997-05-28
BR9507752A (pt) 1997-10-07
NO964966D0 (no) 1996-11-22
CA2191213C (en) 2008-03-18
FI119059B (fi) 2008-07-15
NO316644B1 (no) 2004-03-22
FI964681L (fi) 1997-01-08

Similar Documents

Publication Publication Date Title
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
YU15299A (sh) Farmaceutski sastavi
AU635358B2 (en) Transdermal administration of 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
BG102781A (en) Isolated dimer fibroblastactivation protein alpha and its application
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
DE69905170D1 (en) Thiazolopyrimidinderivate
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
BG102667A (en) Diosgenine-containing composition
BG100248A (bg) Инхибитори на скваленсинтетаза
AU6849198A (en) Neurotrypsin
ATE28188T1 (de) Antikonvulsive mittel.
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
AU580890B2 (en) P-acylaminobenzamides
BG102937A (en) Zona pelucida proteins as contraceptives
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees